Dr. Frias is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
2010 Wilshire Blvd.
Suite 303
Los Angeles, CA 90057Phone+1 213-413-2500- Is this information wrong?
Summary
- Dr. Juan Frias is an endocrinologist in Los Angeles, CA and is affiliated with VA San Diego Healthcare System. He received his medical degree from Vanderbilt University School of Medicine and has been in practice 28 years. He specializes in diabetes and lipid metabolism.
Education & Training
- University of California (San Diego) Medical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 1997 - 1999
- University of TennesseeResidency, Internal Medicine, 1995 - 1997
- Vanderbilt University Medical CenterResidency, Internal Medicine, 1994 - 1995
- US Naval HospitalInternship, Internal Medicine, 1989 - 1990
- Vanderbilt University School of MedicineClass of 1989
Certifications & Licensure
- CA State Medical License 1997 - 2025
- FL State Medical License 1991 - 2014
- CO State Medical License 2001 - 2003
- TN State Medical License 1995 - 1997
Awards, Honors, & Recognition
- Fellow (FACE) American Association of Clinical Endocrinology
Clinical Trials
- Glycemic Response to Road Cycling in Type 1 Diabetes Start of enrollment: 2011 May 01
- A Study to Evaluate BMS-986036 in Obese Adults With Type-2 Diabetes Start of enrollment: 2014 Apr 15
- A Study of LY2409021 in Participants With Type 2 Diabetes Mellitus Start of enrollment: 2014 Apr 01
- Join now to see all
Publications & Presentations
PubMed
- 9 citationsObesity among Latinx people in the United States: A review.José Orlando Alemán, Jaime P Almandoz, Juan Pablo Frias, Rodolfo J Galindo> ;Obesity. 2023 Feb 1
- 20 citationsSafety, pharmacokinetics, and pharmacodynamics of pegozafermin in patients with non-alcoholic steatohepatitis: a randomised, double-blind, placebo-controlled, phase 1b...Rohit Loomba, Eric J Lawitz, Juan Pablo Frias, Grisell Ortiz-Lasanta, Lars Johansson, Bridgette Boggess Franey, Linda Morrow, Moti Rosenstock, Cynthia L Hartsfield, Ch...> ;The Lancet. Gastroenterology & Hepatology. 2023 Feb 1
- Tirzepatide versus Semaglutide Once Weekly in Type 2 Diabetes. Reply.Frías JP, Fernández Landó L, Brown K> ;The New England journal of medicine.
- Join now to see all
Press Mentions
- Noninvasive Liver Screening Technology Enables Providers to Detect Liver Disease in Asymptomatic Patients, Identify at-Risk Patients for ReferralJune 9th, 2022
- Echosens Underscores Impact of Obesity in Nonalcoholic Fatty Liver Disease & Metabolic Syndrome, Emphasizes Role of FibroScan to Monitor Liver Stiffness and Fat at Point-of-CareSeptember 15th, 2021
- SURPASS-3: Tirzepatide Superior to Basal Insulin for HbA1c, Body Weight ReductionAugust 10th, 2021
- Join now to see all
Professional Memberships
- Member
Hospital Affiliations
- Jennifer Moreno Department of Veterans Affairs Medical CenterSan Diego, California
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: